Exceptional response to PD-1 inhibition immunotherapy in advanced metastatic osteosarcoma with tumor site infection

Recent clinical trials have demonstrated a lack of activity of immune checkpoint inhibitors (ICIs) against osteosarcoma. Previous clinical observations have demonstrated a potential immune-stimulatory effect of tumor site infection for osteosarcoma patients. However, whether such infection could aug...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Meng, Bao, Qiyuan, Zhang, Zhusheng, Wang, Beichen, Liu, Zhuochao, Wen, Junxiang, Wan, Rong, Shen, Yuhui, Zhang, Weibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472102/
http://dx.doi.org/10.1136/jitc-2022-004673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472102/
http://dx.doi.org/10.1136/jitc-2022-004673

Ejemplares similares